Team:Arizona State

From 2012.igem.org

(Difference between revisions)
Line 1: Line 1:
{{:Team:Arizona_State/Template:Header}}
{{:Team:Arizona_State/Template:Header}}
-
 
+
<p>
-
 
+
Diarrheic pathogens including E.coli O157:H7 serotype, campylobacter, shigella, and salmonella often contaminate drinking water supplies in developing nations and are responsible for approximately 1.5 million worldwide annual deaths.  Current technologies for detection of bacteria include DNA hybridization FRET signaling, electrical detection via immobilized antimicrobial peptides, and PCR amplification followed by gel visualization.  Our method of bacterial detection fills a niche in biosensor technology.  Our design implies lower costs, higher portability, and a more rapid signal output than most bacterial biosensors.  Additionally, our interchangeable DNA probe confers modularity, allowing for a range of bacterial detection.  Using a novel split beta-galactosidase complementation assay, we have designed three unique chimeric proteins that recognize and bind to specific pathogenic markers and create a functioning beta-galactosidase enzyme. This functioning enzyme unit then cleaves x-gal and produces a colorimetric output signal. Our research demonstrates success in initial stages of chimeric protein assembly.  
-
Abhi, here's the flash file: [[File:Untitled-1.swf|center|some caption]]
+
</p>
-
 
+
-
What we need:
+
-
<ul>
+
-
<li>pics
+
-
<li>text for each pic
+
-
<li>font style for text
+
-
<li>border style (if wanted)
+
-
<li>figure out how to actually show it on the home page...
+
-
</ul>
+

Revision as of 05:14, 8 September 2012

Diarrheic pathogens including E.coli O157:H7 serotype, campylobacter, shigella, and salmonella often contaminate drinking water supplies in developing nations and are responsible for approximately 1.5 million worldwide annual deaths. Current technologies for detection of bacteria include DNA hybridization FRET signaling, electrical detection via immobilized antimicrobial peptides, and PCR amplification followed by gel visualization. Our method of bacterial detection fills a niche in biosensor technology. Our design implies lower costs, higher portability, and a more rapid signal output than most bacterial biosensors. Additionally, our interchangeable DNA probe confers modularity, allowing for a range of bacterial detection. Using a novel split beta-galactosidase complementation assay, we have designed three unique chimeric proteins that recognize and bind to specific pathogenic markers and create a functioning beta-galactosidase enzyme. This functioning enzyme unit then cleaves x-gal and produces a colorimetric output signal. Our research demonstrates success in initial stages of chimeric protein assembly.